Frequency of occurrence by risk-based response to infusion reaction upon rituximab administration in patients with B-cell non-Hodgkin's lymphoma
Not Applicable
- Conditions
- B-cell non-Hodgkin's lymphoma
- Registration Number
- JPRN-UMIN000032309
- Lead Sponsor
- ihon University Itabashi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 83
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have been treated with rituximab in the past
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence rate of infusion reaction in each risk group at the time of initial administration of rituximab
- Secondary Outcome Measures
Name Time Method